Cargando…
Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
BACKGROUND: Progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) dementia can be predicted by clinical features and a combination of biomarkers may increase the predictive power. In the present study, we investigated whether the combination of olfactory function and plasma neur...
Autores principales: | Zhao, Aonan, Li, Yuanyuan, Yan, Yi, Qiu, Yinghui, Li, Binyin, Xu, Wei, Wang, Ying, Liu, Jun, Deng, Yulei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397685/ https://www.ncbi.nlm.nih.gov/pubmed/32741361 http://dx.doi.org/10.1186/s40035-020-00210-5 |
Ejemplares similares
-
Visual Abnormalities Associate With Hippocampus in Mild Cognitive Impairment and Early Alzheimer's Disease
por: Zhao, Aonan, et al.
Publicado: (2021) -
Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer’s disease
por: Zhao, Aonan, et al.
Publicado: (2022) -
Relationship Between FERMT2, CELF1, COPI, CHRNA2, and ABCA7 Genetic Polymorphisms and Alzheimer’s Disease Risk in the Southern Chinese Population
por: Ding, Yanfei, et al.
Publicado: (2023) -
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017) -
Amyloid biomarkers as predictors of conversion from mild cognitive impairment to Alzheimer’s dementia: a comparison of methods
por: Sörensen, Arnd, et al.
Publicado: (2020)